Work

Genome-wide association study of antipsychotic-induced QTc interval prolongation

Year: 2010

Type: article

Source: The Pharmacogenomics Journal

DOI: 10.1038/tpj.2010.76

Authors: K Åberg, D E Adkins, Y Liu, J L McClay, J Bukszár, P Jia, Z Zhao, D Perkins, T S Stroup, J A Lieberman, P F Sullivan, E J C G van den Oord

Institutions: Virginia Commonwealth University, Virginia Commonwealth University Medical Center, University of North Carolina at Chapel Hill, Vanderbilt University Medical Center, Columbia University, Karolinska Institutet

Language: English

Topic: Cardiac electrophysiology and arrhythmias

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Otsuka Pharmaceutical, National Institutes of Health, National Institute of Mental Health, Janssen Pharmaceuticals

Awards: G1121004391, Integrating Genomic and Environmental Perspectives on Internalizing Disorders, Learning Adaptive Treatment Strategies in Mental Health, G445903376, CLINICAL ANTIPSYCHOTIC TRIALS OF INTERVENTION EFFECTIVES, G8700482840

OpenAlex ID: W2000703937

FWCI: 5.718

Cites: 42

Cited by: 87

Related to: 10